Trials / Conditions / Leukemia, Lymphoblastic, Acute

Leukemia, Lymphoblastic, Acute

23 registered clinical trials studyying Leukemia, Lymphoblastic, Acute.

Status	Trial	Sponsor	Phase
Completed	Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Ped NCT03627208	National Cancer Institute (NCI)	—
Unknown	Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelod NCT03235973	Institut Paoli-Calmettes	Phase 1
Unknown	Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EB NCT03331211	Nanfang Hospital, Southern Medical University	—
Completed	Administration of Donor MultiTAA-Specific T Cells for ALL NCT02475707	Baylor College of Medicine	Phase 1
Completed	Phase I, Dose Escalation Study of Decitabine NCT02264873	University of Florida	Phase 1
Completed	Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation NCT01700751	Washington University School of Medicine	Phase 1
Completed	Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia NCT01976442	University of Rochester	—
Terminated	EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (A NCT01186328	Therapeutic Advances in Childhood Leukemia Consortium	Phase 1
Terminated	Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia NCT01158885	Therapeutic Advances in Childhood Leukemia Consortium	Phase 2
Terminated	MSC and HSC Coinfusion in Mismatched Minitransplants NCT01045382	University of Liege	Phase 2
Terminated	Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors NCT01100658	University of Minnesota	N/A
Completed	Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia. NCT01041508	Therapeutic Advances in Childhood Leukemia Consortium	Phase 1
Unknown	Unrelated Double Umbilical Cord Blood Units Transplantation NCT01015742	Tehran University of Medical Sciences	Phase 2 / Phase 3
Terminated	Pilot Study of Unrelated Cord Blood Transplantation NCT00916045	King's College Hospital NHS Trust	Phase 2
Completed	Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation NCT00859586	National Heart, Lung, and Blood Institute (NHLBI)	N/A
Terminated	Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers NCT00539656	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 1 / Phase 2
Completed	"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients NCT00475280	Gruppo Italiano Malattie EMatologiche dell'Adulto	Phase 2
Completed	Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia NCT02888990	Versailles Hospital	Phase 2
Completed	Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies NCT00619879	Ann & Robert H Lurie Children's Hospital of Chicago	—
Completed	Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H NCT00458250	Tehran University of Medical Sciences	Phase 1
Completed	Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malign NCT00241358	Washington University School of Medicine	Phase 1 / Phase 2
Completed	A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors NCT00186901	St. Jude Children's Research Hospital	Phase 3
Completed	Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) NCT00179764	Ann & Robert H Lurie Children's Hospital of Chicago	N/A